在廣播道上打滾近三十年，問我最敬畏的是誰？肯定是俞琤（YT）。 在商台的日子，有幸與YT近身工作，與她開會是「天花板級的地獄」，以為想到甚麼好蹺，能博得她稱讚麼？每次只被她批評得體無完膚，然後她就在我們面前拋出一條絕世好橋，而我只能垂頭喪氣地離開她的辦公室。 YT對用字、用聲與時間掌握之嚴謹也是「天花板級」的。試過主持深宵節目時，她忽然來電，只說了一句：「你頭先講咗啲乜？」然後便掛綫；也試過與她在錄音室錄製電台宣傳聲帶，她親自操刀，錄了近一百take，仍不滿意。作為她的下屬，雖然一點也不好受，但感恩有幸經歷過如此煉獄般的特訓，當中所學到的，畢生受用。 離開電台後，有幸與YT保持聯繫。記得第一套電影《王家欣》上畫前，我大膽邀請她來看試片，YT二話不說，話嚟就嚟，看完後還邀請我到她家促膝而談。記得她說：「你搵得我嚟，唔係諗住我睇完會讚你㗎可？」然後她將意見及改善方法毫不保留地告訴我，又動用她的人脈來幫助我宣傳，當時實在感激不已。後來每部電影上畫前，我也會先邀請YT到試片室觀看，她每次都嚟，每次都字字珠璣，沒有半句廢話，說完便瀟灑離去。 廣播道上人才輩出，我沒資格做YT的徒弟或愛將，但在我心中，她肯定是我的恩師。能夠從YT口中得到嘉許，是人生一大成就，遺憾至今我從未得到YT的稱讚，反而數月前，她竟在本欄中找到一個錯處，然後發短訊給我，當時實在慚愧得無地自容。 數天前，突然收到YT的短訊，一張圖、四隻字：「如果你嚟」，原來是她為了心光盲人院暨學校籌款而出山，我馬上回覆她：「我一定嚟！」以我認識的YT，箭無虛發，如果你在YuTsang.com上還搶到飛的話，建議你一定要嚟。 Source link
Human beings have touched every single corner of this pale blue dot that we call home, summiting each one of the highest mountains in the world and marching through the frozen tundras of its polar caps to prove our mastery over the Earth’s surface. But while human curiosity and ingenuity drove us to explore distant
Scientists claim that 62 million women in the US are living with some type of cardiovascular health which is prokected to spike by 2050. Heart disease is a leading cause of death for women in the United States, which can affect women of all ages. A report published by the Centres for Disease Control and
Home » Greece » Greece Aims to Dominate Global Wellness Tourism as Travelers Seek Health and Lifestyle-Focused Experiences Published on February 28, 2026 Image generated with Ai Greece is preparing to establish itself as a premier destination in the expanding global wellness tourism sector, projected to surpass $1.3 trillion by 2028. As international travelers increasingly
Home / News / GLP-1 drugs combined with healthy lifestyle habits linked with reduced cardiovascular risk among diabetes patients Hide caption Show caption aprott / iStock For immediate release: February 25, 2026 Boston, MA—Individuals living with type 2 diabetes (T2D) had a significantly lower risk of poor cardiovascular health when they used a GLP-1 receptor
